Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic combinations comprising anti-CD123 immunoconjugates

Therapeutic combinations comprising anti-CD123 immunoconjugates

US Patent 11701428 · Granted Jul 18, 2023

Estimated economic value: $173,097,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for improving anti-CD37 immunoconjugate therapy2022
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies2018
Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies2017
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies2016
Bispecific anti-IGF-1R and anti-ErbB3 antibodies2013
Hybrid peptides modulate the immune response2009
Hybrid peptides modulate the immune response2007
Hematopoietic stimulation2006
Ii peptide therapeutics to enhance antigen presentation2004
Hematopoietic stimulation2004
Hybrid peptides modulate the immune response2002
Hematopoietic stimulation2001